Prescribing off-label COVID boosters may put providers at legal risk: report
By
Alicia Lasek
Sep 06, 2021
Clinicians who provide additional COVID-19 shots to fully vaccinated patients may be at risk for legal claims if they prescribe the doses outside of current federal guidelines, CDC says.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
FDA expands COVID booster shot access; says vaccines can be mixed or matched
By
Alicia Lasek
Oct 21, 2021
The agency has amended the emergency use authorizations for Moderna’s and Johnson & Johnson’s COVID-19 vaccines to allow for the use of a single booster dose in certain eligible groups.
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.